Skip to main content

Subcutaneous Biosimilar: Dr. Jonathan Kay

Nov 20, 2019 11:34 am
Dr. Kay highlights abstract #548 presented at the 2019 ACR/ARP annual meeting in Atlanta.

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×